Cogent Biosciences, Inc. (COGT)
36.23
-0.50
(-1.36%)
USD |
NASDAQ |
Aug 24, 16:00
36.23
0.00 (0.00%)
After-Hours: 19:54
Cogent Biosciences Shareholders Equity (Quarterly) : 532.39M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 532.39M |
| March 31, 2026 | 607.69M |
| December 31, 2025 | 636.37M |
| September 30, 2025 | 302.46M |
| June 30, 2025 | 155.04M |
| March 31, 2025 | 219.00M |
| December 31, 2024 | 256.29M |
| September 30, 2024 | 314.66M |
| June 30, 2024 | 373.22M |
| March 31, 2024 | 422.33M |
| December 31, 2023 | 257.80M |
| September 30, 2023 | 302.90M |
| June 30, 2023 | 348.43M |
| March 31, 2023 | 223.56M |
| December 31, 2022 | 255.74M |
| September 30, 2022 | 289.94M |
| June 30, 2022 | 319.38M |
| March 31, 2022 | 187.86M |
| Date | Value |
|---|---|
| December 31, 2021 | 214.18M |
| September 30, 2021 | 197.24M |
| June 30, 2021 | 212.80M |
| March 31, 2021 | 226.76M |
| December 31, 2020 | 234.67M |
| September 30, 2020 | -22.17M |
| June 30, 2020 | 19.24M |
| March 31, 2020 | 25.70M |
| December 31, 2019 | 31.76M |
| September 30, 2019 | 28.62M |
| June 30, 2019 | 39.76M |
| March 31, 2019 | 49.29M |
| December 31, 2018 | 60.23M |
| September 30, 2018 | 67.53M |
| June 30, 2018 | 76.68M |
| March 31, 2018 | 15.90M |
| December 31, 2017 | 28.30M |
| September 30, 2017 | 34.48M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Apogee Therapeutics, Inc. | 1.195B |
| ImmunityBio, Inc. | -1.047B |
| Erasca, Inc. | 361.87M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 834.55M |
| Total Liabilities (Quarterly) | 302.16M |
| Debt to Equity Ratio | 0.4588 |
| Current Ratio | 13.57 |
| Net Debt Paydown Yield | -0.68% |